Skip to content

Homeopathic treatment of knee pain

Individualized homoeopathic medicines in pain management of knee osteoarthritis in perimenopausal women with special emphasis on complete symptoms: A double-blind, randomized, placebo-controlled, phase IIb pilot trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/041660
Enrollment
60
Registered
2022-04-05
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within
dosage and repetition were maintained depending upon the individual requirement of the cases. All sundry items

Sponsors

D N De Homeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from osteoarthritis of knee joints (ICD -10 code -M 17.9) since last 3 months. 2. American College of Rheumatology 2019 diagnostic criteria of knee osteoarthritis using history, physical examination and radiographic findings – pain in the knee and one of the following - (a) age over 50 years, (b) morning stiffness less than 30 min, and (c) crepitus on active motion and osteophytes on x-ray. 3. Age between 40 and 55 years 4. Female patients of perimenopausal age 5. Patient having complete symptom, i.e., location, sensation, modality and/or concomitant(s). 6. Literate patients; ability to read English and/or Bengali 7. Providing written informed consent to participate.

Exclusion criteria

Exclusion criteria: 1. Severe degeneration of knee joint with mark joint narrowing, varus, or valgus deformity of knee; as evidenced by imaging or other evidences and requiring surgical intervention. 2. Self-reported joint disorders other than osteoarthritis (e.g., inflammatory joint disease, specific arthropathy, hyperuricemia and/or gout, severe axis deviations or instabilities, joint or skin infections, joint prostheses of the lower limbs) 3. Intra-articular injections within 2 weeks before study entry. 4. Transplanted knees. 5. Non-ambulant patient. 6. Obese patient (body mass index 30.0 or more). 7. Recent significant knee surgery within last 6 months 8. Vulnerable population - unconscious, ambulatory, too seek for consultation, differently abled, terminally or critically ill patients, mentally incompetent people. 9. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life threatening illness affecting quality of life or any organ failure. 10. Pregnant and puerperal women, lactating mothers. 11. Patients with habits of tobacco chewing and/or smoking, alcoholism and/or any other form (s) of substance abuse and/or dependence. 12. Self-reported immune-compromised state, and 13. Already undergoing homeopathic treatment for chronic disease within last 6 months.

Design outcomes

Primary

MeasureTime frame
Knee injury and osteoarthritis outcome score (KOOS)Timepoint: At baseline, and every month, up to 3 months

Secondary

MeasureTime frame
EQ-5D-5L and EQ-VASTimepoint: At baseline, and every month, up to 3 months;Frequency of add-on paracetamol and/or NSAIDs use during study period of 3 monthsTimepoint: At baseline, and every month, up to 3 months

Countries

India

Contacts

Public ContactProf Dr Subhasish Ganguly

D. N. De Homeopathic Medical College and Hospital

ganguly.subhasish@rediffmail.com9007263548

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026